Evidence map›Paper›PMID 39049963›Full record

ArticleGates open research2021

Using maternal and neonatal data collection systems for coronavirus disease 2019 (COVID-19) vaccines active safety surveillance in low- and middle-income countries: an international modified Delphi study.

Veronica Pingray, María Belizán, Sarah Matthews, Sabra Zaraa, Mabel Berrueta, Lisa M Noguchi, Xu Xiong, Alejandra Gurtman, Judith Absalon, Jennifer C Nelson and 12 more

Abstract read
In one paragraph

Article in Gates open research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Veronica PingrayInstitute for Clinical Effectiveness and Health Policy (IECS-CONICET), Ciudad de Buenos Aires, Buenos Aires, 1414, Argentina.ORCID https://orcid.org/0000-0002-7889-2825
María BelizánInstitute for Clinical Effectiveness and Health Policy (IECS-CONICET), Ciudad de Buenos Aires, Buenos Aires, 1414, Argentina.
Sarah MatthewsSchool of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana, 70112, USA.
Sabra ZaraaSchool of Pharmacy, University of Washington, Seattle, Washington, 98195, USA.
Mabel BerruetaInstitute for Clinical Effectiveness and Health Policy (IECS-CONICET), Ciudad de Buenos Aires, Buenos Aires, 1414, Argentina.ORCID https://orcid.org/0000-0001-7915-5643
Lisa M NoguchiJhpiego, Johns Hopkins University, Baltimore, Maryland, 21231, USA.
Xu XiongSchool of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana, 70112, USA.ORCID https://orcid.org/0000-0001-9292-5059
Alejandra GurtmanVaccine Research and Development, Pfizer, Inc, Pearl River, New York, 10965, USA.
Judith AbsalonVaccine Research and Development, Pfizer, Inc, Pearl River, New York, 10965, USA.
Jennifer C NelsonKaiser Permanente, Washington Health Research Institute, Seattle, Washington, 98101, USA.
Lakshmi PanagiotakopoulosCenters for Disease Control and Prevention, Atlanta, Georgia, 30333, USA.
Esperanca SeveneDepartment of Physiological Science, Clinical Pharmacology, Faculty of Medicine , Maputo, Mozambique, Eduardo Mondlane University/Manhiça Health Research Centre, Maputo, Maputo, 1102, Mozambique.
Flor M MunozDepartments of Pediatrics, Molecular Virology and Microbiology,, Baylor College of Medicine, Houston, Texas, 77004, USA.
Fernando AlthabeUNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Geneva, 1211, Switzerland.
Kissa W MwamwitwaTanzania Medicines and Medical Devices Authority, Dar es Salaam, Tanzania, 11000, Tanzania.ORCID https://orcid.org/0000-0001-9106-6707
Federico Rodriguez CairoliInstitute for Clinical Effectiveness and Health Policy (IECS-CONICET), Ciudad de Buenos Aires, Buenos Aires, 1414, Argentina.
Steven A AndersonU. S. Food & Drug Administration, Silver Spring, Maryland, 20993, USA.
Elizabeth M McClureSocial, Statistical and Environmental Sciences, Research Triangle Institute, Durham, North Carolina, 27709, USA.ORCID https://orcid.org/0000-0001-8659-5444
Christine GuillardWorld Health Organization, Geneva, Geneva, 1211, Switzerland.
Annettee NakimuliDepartment of Obstetrics and Gynaecology, School of Medicine, Makerere University, Kampala, Kampala, 0000, Uganda.
Andy StergachisSchool of Pharmacy, University of Washington, Seattle, Washington, 98195, USA.
Pierre BuekensSchool of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana, 70112, USA.

Funding

Bill & Melinda Gates Foundation INV-008443World Health Organization 001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

active safety surveillanceCOVID-19 vaccineDelphi Techniquepregnancy

Identifiers

PMID39049963
PMCPMC11266593

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.